ImmunityBio
IBRX
IBRX
95 hedge funds and large institutions have $70.4M invested in ImmunityBio in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
44% less call options, than puts
Call options by funds: $2.68M | Put options by funds: $4.8M
45% less capital invested
Capital invested by funds: $129M → $70.4M (-$58.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
95
Holding in Top 10
–
Calls
$2.68M
Puts
$4.8M
Top Buyers
| 1 | +$4.28M | |
| 2 | +$2.98M | |
| 3 | +$924K | |
| 4 |
MOACM
Mutual of America Capital Management
New York
|
+$854K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$741K |
Top Sellers
| 1 | -$9.68M | |
| 2 | -$5.51M | |
| 3 | -$4.3M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.27M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.47M |